Copyright: ©Author(s) 2026.
World J Psychiatry. Sep 19, 2026; 16(9): 119511
Published online Sep 19, 2026. doi: 10.5498/wjp.119511
Published online Sep 19, 2026. doi: 10.5498/wjp.119511
Table 1 Clinical characteristics of patients undergoing maintenance hemodialysis, n (%)/mean ± SD
| Characteristics | Observation group (n = 85) | Control group (n = 73) | P value |
| Age | 45.20 ± 6.54 | 43.41 ± 7.26 | 0.105 |
| Sex | 0.492 | ||
| Male | 49 (57.65) | 46 (63.01) | |
| Female | 36 (42.35) | 27 (36.99) | |
| BMI (kg/m2) | 21.40 ± 3.37 | 21.15 ± 2.94 | 0.636 |
| Dialysis vintage | 0.563 | ||
| 1-3 years | 47 (55.29) | 36 (49.32) | |
| > 3 years | 38 (44.71) | 37 (50.68) | |
| Employment status | 0.941 | ||
| Employed | 43 (50.59) | 35 (47.95) | |
| Unemployed | 27 (31.76) | 24 (32.88) | |
| Retired | 15 (17.65) | 14 (19.18) | |
| Marital status | 0.500 | ||
| Married | 70 (82.35) | 57 (78.08) | |
| Single | 15 (17.65) | 16 (21.92) | |
| Education level | 0.643 | ||
| Junior high school and below | 33 (38.82) | 29 (39.73) | |
| High school or junior college | 42 (49.41) | 32 (43.84) | |
| College and above | 10 (11.76) | 12 (16.44) | |
| Per capita monthly household income (RMB) | 0.436 | ||
| ≤ 3000 | 46 (54.12) | 44 (60.27) | |
| > 3000 | 39 (45.88) | 29 (39.73) | |
| Form of payment | 1.0001 | ||
| Self-financed | 2 (2.35) | 2 (2.74) | |
| Medical insurance | 83 (97.65) | 71 (97.26) | |
| Primary disease | 0.911 | ||
| Diabetes | 30 (35.29) | 24 (32.88) | |
| Hypertension | 18 (21.18) | 18 (24.66) | |
| Chronic glomerulonephritis | 25 (29.41) | 18 (24.66) | |
| Polycystic kidney disease | 7 (8.24) | 7 (9.59) | |
| Others | 5 (5.88) | 6 (8.22) | |
| Hb (g/L) | 113.73 ± 12.59 | 111.16 ± 12.13 | 0.193 |
| Serum albumin (g/L) | 40.05 ± 4.42 | 39.06 ± 3.11 | 0.111 |
| Serum calcium (mmol/L) | 2.40 ± 0.48 | 2.51 ± 0.38 | 0.117 |
| Serum phosphorus (mmol/L) | 1.90 ± 0.42 | 1.86 ± 0.38 | 0.535 |
| Kt/V | 1.23 ± 0.33 | 1.20 ± 0.26 | 0.551 |
| Urea reduction ratio (%) | 65.04 ± 15.61 | 62.14 ± 17.35 | 0.270 |
Table 2 Comparison of stigma, mean ± SD
| Characteristics | Observation group (n = 85) | Control group (n = 73) | P1 |
| Total SIS score | |||
| Pre-intervention | 70.04 ± 7.57 | 70.98 ± 8.29 | 0.458 |
| Post-intervention | 51.06 ± 9.08 | 63.62 ± 8.31 | < 0.001 |
| P2 | < 0.001 | < 0.001 | - |
| Social exclusion | |||
| Pre-intervention | 25.64 ± 4.82 | 25.56 ± 5.98 | 0.926 |
| Post-intervention | 18.09 ± 4.26 | 23.33 ± 4.91 | < 0.001 |
| P2 | < 0.001 | 0.015 | - |
| Financial insecurity | |||
| Pre-intervention | 9.62 ± 2.71 | 9.58 ± 2.83 | 0.928 |
| Post-intervention | 7.41 ± 2.85 | 9.37 ± 2.64 | < 0.001 |
| P2 | < 0.001 | 0.644 | - |
| Internalized shame | |||
| Pre-intervention | 16.03 ± 2.24 | 16.65 ± 2.18 | 0.081 |
| Post-intervention | 11.24 ± 3.62 | 14.73 ± 2.32 | < 0.001 |
| P2 | < 0.001 | < 0.001 | - |
| Social isolation | |||
| Pre-intervention | 18.75 ± 4.66 | 19.10 ± 4.49 | 0.633 |
| Post-intervention | 14.32 ± 5.02 | 16.19 ± 3.45 | 0.008 |
| P2 | < 0.001 | < 0.001 | - |
Table 3 Comparison of negative emotions, mean ± SD
Table 4 Comparison of treatment adherence rates, mean ± SD
| Characteristics | Observation group (n = 85) | Control group (n = 73) | P1 |
| Total treatment adherence | |||
| Pre-intervention | 626.38 ± 54.51 | 622.02 ± 49.91 | 0.603 |
| Post-intervention | 835.07 ± 64.06 | 656.41 ± 67.28 | < 0.001 |
| P2 | < 0.001 | < 0.001 | - |
| Treatment adherence | |||
| Pre-intervention | 275.11 ± 35.62 | 270.02 ± 37.11 | 0.381 |
| Post-intervention | 355.34 ± 33.74 | 284.47 ± 41.15 | < 0.001 |
| P2 | < 0.001 | 0.027 | - |
| Medication adherence | |||
| Pre-intervention | 95.24 ± 24.57 | 96.84 ± 19.12 | 0.653 |
| Post-intervention | 140.15 ± 36.18 | 103.01 ± 34.11 | < 0.001 |
| P2 | < 0.001 | 0.180 | - |
| Fluid restrictions | |||
| Pre-intervention | 123.02 ± 16.87 | 121.91 ± 13.54 | 0.653 |
| Post-intervention | 170.75 ± 18.20 | 129.33 ± 21.26 | < 0.001 |
| P2 | < 0.001 | 0.013 | - |
| Diet recommendations | |||
| Pre-intervention | 133.01 ± 28.54 | 133.25 ± 23.77 | 0.959 |
| Post-intervention | 168.82 ± 24.44 | 139.60 ± 31.19 | < 0.001 |
| P2 | < 0.001 | 0.169 | |
Table 5 Comparison of sleep quality, mean ± SD
| Characteristics | Observation group (n = 85) | Control group (n = 73) | P1 |
| Total PSQI score | |||
| Pre-intervention | 8.71 ± 1.08 | 8.73 ± 1.09 | 0.908 |
| Post-intervention | 6.60 ± 1.94 | 8.11 ± 2.14 | < 0.001 |
| P2 | < 0.001 | 0.029 | - |
| Subjective sleep quality | |||
| Pre-intervention | 1.13 ± 0.36 | 1.21 ± 0.42 | 0.199 |
| Post-intervention | 0.91 ± 0.37 | 0.95 ± 0.40 | 0.515 |
| P2 | < 0.001 | < 0.001 | - |
| Sleep latency | |||
| Pre-intervention | 1.30 ± 0.43 | 1.28 ± 0.39 | 0.761 |
| Post-intervention | 1.01 ± 0.42 | 1.23 ± 0.46 | 0.002 |
| P2 | < 0.001 | 0.480 | - |
| Sleep duration | |||
| Pre-intervention | 0.98 ± 0.45 | 1.04 ± 0.44 | 0.417 |
| Post-intervention | 0.82 ± 0.41 | 1.19 ± 0.43 | < 0.001 |
| P2 | 0.016 | 0.039 | - |
| Habitual sleep efficiency | |||
| Pre-intervention | 1.41 ± 0.44 | 1.39 ± 0.46 | 0.781 |
| Post-intervention | 0.94 ± 0.39 | 1.30 ± 0.49 | < 0.001 |
| P2 | < 0.001 | 0.255 | - |
| Sleep disturbances | |||
| Pre-intervention | 1.41 ± 0.37 | 1.38 ± 0.45 | 0.646 |
| Post-intervention | 1.04 ± 0.42 | 1.27 ± 0.48 | 0.002 |
| P2 | < 0.001 | 0.155 | - |
| Use of sleep medications | |||
| Pre-intervention | 1.06 ± 0.30 | 1.02 ± 0.26 | 0.376 |
| Post-intervention | 0.85 ± 0.39 | 0.90 ± 0.34 | 0.396 |
| P2 | < 0.001 | 0.018 | - |
| Daytime dysfunction | |||
| Pre-intervention | 1.42 ± 0.47 | 1.41 ± 0.39 | 0.886 |
| Post-intervention | 1.04 ± 0.42 | 1.26 ± 0.53 | 0.004 |
| P2 | < 0.001 | 0.053 | - |
Table 6 Comparison of quality of life, mean ± SD
| Characteristics | Observation group (n = 85) | Control group (n = 73) | P1 |
| PF | |||
| Pre-intervention | 57.42 ± 13.01 | 58.87 ± 12.45 | 0.477 |
| Post-intervention | 73.64 ± 15.57 | 62.60 ± 16.73 | < 0.001 |
| P2 | < 0.001 | 0.129 | - |
| RP | |||
| Pre-intervention | 54.62 ± 11.33 | 53.87 ± 9.94 | 0.661 |
| Post-intervention | 63.76 ± 14.91 | 56.26 ± 11.87 | < 0.001 |
| P2 | < 0.001 | 0.189 | - |
| BP | |||
| Pre-intervention | 62.53 ± 14.92 | 61.87 ± 8.05 | 0.736 |
| Post-intervention | 74.49 ± 15.47 | 66.12 ± 12.45 | < 0.001 |
| P2 | < 0.001 | 0.016 | - |
| GH | |||
| Pre-intervention | 36.28 ± 14.12 | 35.91 ± 11.02 | 0.856 |
| Post-intervention | 63.25 ± 12.36 | 40.67 ± 15.47 | < 0.001 |
| P2 | < 0.001 | 0.022 | - |
| VT | |||
| Pre-intervention | 41.16 ± 9.81 | 40.88 ± 8.29 | 0.848 |
| Post-intervention | 53.85 ± 9.16 | 41.34 ± 10.65 | < 0.001 |
| P2 | < 0.001 | 0.771 | - |
| RE | |||
| Pre-intervention | 42.13 ± 15.04 | 40.97 ± 11.21 | 0.589 |
| Post-intervention | 63.41 ± 11.60 | 45.22 ± 12.33 | < 0.001 |
| P2 | < 0.001 | 0.031 | - |
| MH | |||
| Pre-intervention | 57.02 ± 10.11 | 56.87 ± 8.84 | 0.922 |
| Post-intervention | 65.36 ± 12.28 | 60.16 ± 9.90 | 0.004 |
| P2 | < 0.001 | 0.036 | - |
| SF | |||
| Pre-intervention | 64.82 ± 10.98 | 65.67 ± 8.65 | 0.594 |
| Post-intervention | 85.38 ± 11.55 | 73.74 ± 10.46 | < 0.001 |
| P2 | < 0.001 | < 0.001 | - |
Table 7 Comparison of changes in indicators (pre- vs post-treatment)
| Characteristics | Difference score according to baseline | P value | |
| Observation group (n = 85) | Control group (n = 73) | ||
| Total SIS score | -18.00 (-26.00, -11.00) | -8.00 (-15.00, 0.00) | < 0.001 |
| Social exclusion | -8.00 (-12.00, -3.00) | -2.00 (-8.00, 2.00) | < 0.001 |
| Financial insecurity | -2.00 (-5.00, 1.00) | 0.00 (-3.00, 3.00) | 0.002 |
| Internalized shame | -5.00 (-8.00, -2.00) | -1.00 (-3.00, 0.00) | < 0.001 |
| Social isolation | -6.00 (-10.00, -1.00) | -3.00 (-6.00, 0.00) | 0.017 |
| SAS | -10.00 (-19.00, -3.00) | -3.00 (-9.00, 4.00) | < 0.001 |
| SDS | -9.00 (-15.00, -1.00) | -4.00 (-12.00, 6.00) | 0.029 |
| Total treatment adherence | 231.00 (153.00, 268.00) | 39.00 (-9.00, 79.00) | < 0.001 |
| Treatment adherence | 83.00 (49.00, 117.00) | 13.00 (-21.00, 61.00) | < 0.001 |
| Medication adherence | 48.00 (14.00, 75.00) | 7.00 (-22.00, 29.00) | < 0.001 |
| Fluid restrictions | 49.00 (29.00, 72.00) | 6.00 (-8.00, 21.00) | < 0.001 |
| Diet recommendations | 34.00 (12.00, 63.00) | 7.00 (-19.00, 32.00) | < 0.001 |
| Total PSQI score | -2.00 (-3.00, -1.00) | -1.00 (-2.00, 1.00) | 0.002 |
| Subjective sleep quality | 0.00 (0.00, 0.00) | 0.00 (-1.00, 0.00) | 0.627 |
| Sleep latency | -0.30 (-0.70, 0.10) | -0.10 (-0.40, 0.20) | 0.015 |
| Sleep duration | 0.00 (0.00, 0.00) | 0.00 (0.00, 0.00) | 0.002 |
| Habitual sleep efficiency | -0.50 (-0.80, -0.10) | -0.10 (-0.60, 0.30) | < 0.001 |
| Sleep disturbances | -0.30 (-0.70, -0.10) | -0.20 (-0.70, 0.40) | 0.019 |
| Use of sleep medications | 0.00 (0.00, 0.00) | 0.00 (0.00, 0.00) | 0.183 |
| Daytime dysfunction | -0.30 (-0.70, 0.00) | -0.30 (-0.60, 0.20) | 0.101 |
| PF | 17.00 (5.00, 31.00) | 6.00 (-9.00, 18.00) | < 0.001 |
| RP | 10.00 (-3.00, 22.00) | 1.00 (-10.00, 13.00) | 0.007 |
| BP | 13.00 (0.00, 28.00) | 8.00 (-5.00, 14.00) | 0.014 |
| GH | 27.00 (16.00, 38.00) | 4.00 (-8.00, 18.00) | < 0.001 |
| VT | 13.00 (4.00, 21.00) | -1.00 (-10.00, 9.00) | < 0.001 |
| RE | 19.00 (10.00, 32.00) | 3.00 (-7.00, 15.00) | < 0.001 |
| MH | 7.00 (0.00, 19.00) | 5.00 (-5.00, 11.00) | 0.049 |
| SF | 23.00 (10.00, 31.00) | 7.00 (0.00, 18.00) | < 0.001 |
- Citation: Xu WL, Wang Y, Zhu L, Zhang X, Tan YS, Peng PP, Yang XJ. Impact of narrative support on stigma, anxiety, and depression in young and middle-aged patients undergoing maintenance hemodialysis. World J Psychiatry 2026; 16(9): 119511
- URL: https://www.wjgnet.com/2220-3206/full/v16/i9/119511.htm
- DOI: https://dx.doi.org/10.5498/wjp.119511